Breaking News

Evonik, Heraeus Partner to Expand Range of HPAPI Services

To combine HPAPI capabilities to provide an integrated offering from the preclinical stage to commercial manufacturing.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Evonik and Heraeus Precious Metals are collaborating to expand both companies’ range of services for highly potent active pharmaceutical ingredients (HPAPIs). The alliance leverages specific HPAPI capabilities of both companies to provide an integrated offering from the preclinical stage to commercial manufacturing, including streamlined transfer between small and large-scale production.   Evonik’s Health Care business provides CDMO services for active pharmaceutical ingredients (APIs) and int...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters